This is the authors' abstract. We don't add key points for this paper.
This scoping review of current practice reveals a myriad of outcomes and outcome measurement instruments for clinical trials in GNDs and ID. This complicates generalization, evidence synthesis, and evaluation. It underlines the need for consensus on suitability, validity, and relevancy of instruments, ultimately resulting in a core outcome set. A series of steps is proposed to move from the myriad of measures to a more unified approach.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: